Home > Insider Trading > Filing (0001991925-23-000003)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1173281	Neubase Therapeutics Inc.	NBSE	Pharmaceutical Preparations (2834)	465622433

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1991925	Symetryx Corp	2828 Bathurst St #400 Toronto A6 M6B3A7		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.0001 Per Share	Disposition	2023-09-07	74,852	$1.80	605,149	No	4	S	Direct
Common Stock, Par Value $0.0001 Per Share	Disposition	2023-09-08	128,847	$1.53	476,302	No	4	S	Direct
Common Stock, Par Value $0.0001 Per Share	Disposition	2023-09-11	3,376	$1.44	472,926	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Of the 472,926 shares listed on Table I in Column 5 as beneficially owned by Symetryx Corporation prior to filing this Form 4: Symetryx Corporation beneficially owns 282,445 shares; Barry Shiff, an individual through his retirement accounts, beneficially owns 109,508 shares; and Aleta Shiff, an individual through her retirement accounts, beneficially owns 80,973 shares. As reported on the Schedule 13D dated August 30, 2023, these three shareholders may be deemed to beneficially own the shares of common stock beneficially owned by each other.